Streamline Health Solutions, Inc.
STRMNASDAQHealthcare
$5.33
+$0.00(+0.00%)
Market Cap$23231739
P/E Ratio—
52W High$9.45
52W Low$1.82
Streamline Health Solutions, Inc. (STRM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
STRM · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2025Report Date: Sep 10, 2025EPS Actual
-$0.75
Revenue
—
Fiscal Period
Q3 FY2025
FY ends December
Report Date
Sep 10, 2025
After Market Close
STRM reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q3 FY2025 | Sep 10, 2025 | — | -$0.75 | — | — | — | — |
| ▼ Q2 FY2025 | Jun 16, 2025 | -$0.04 | -$0.40 | -900.0% | $0.00B | $0.00B | +2.3% |
| — Q2 FY2025 | Apr 28, 2025 | — | -$0.53 | — | $0.00B | — | — |
| ▼ Q4 FY2024 | Dec 16, 2024 | -$0.03 | -$0.61 | -1933.3% | $0.00B | $0.01B | -16.6% |
| ▼ Q3 FY2024 | Sep 11, 2024 | -$0.60 | -$0.75 | -25.0% | $0.00B | $0.01B | -15.7% |
| ▼ Q2 FY2024 | Jun 11, 2024 | -$0.60 | -$0.75 | -25.0% | $0.00B | $0.00B | -12.9% |
| ▼ Q2 FY2024 | Apr 29, 2024 | -$0.20 | -$0.30 | -50.0% | $0.01B | $0.01B | -2.4% |
| ▼ Q4 FY2023 | Dec 13, 2023 | -$0.19 | -$0.30 | -55.6% | $0.01B | $0.01B | +11.7% |
Q3 FY2025
Sep 10, 2025
EPS Actual
-$0.75
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Jun 16, 2025Miss
EPS Actual
-$0.40
EPS Est.
-$0.04
EPS Surpr.
-900.0%
Revenue
$0.00B
Q2 FY2025
Apr 28, 2025
EPS Actual
-$0.53
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2024
Dec 16, 2024Miss
EPS Actual
-$0.61
EPS Est.
-$0.03
EPS Surpr.
-1933.3%
Revenue
$0.00B
Q3 FY2024
Sep 11, 2024Miss
EPS Actual
-$0.75
EPS Est.
-$0.60
EPS Surpr.
-25.0%
Revenue
$0.00B
Q2 FY2024
Jun 11, 2024Miss
EPS Actual
-$0.75
EPS Est.
-$0.60
EPS Surpr.
-25.0%
Revenue
$0.00B
Q2 FY2024
Apr 29, 2024Miss
EPS Actual
-$0.30
EPS Est.
-$0.20
EPS Surpr.
-50.0%
Revenue
$0.01B
Q4 FY2023
Dec 13, 2023Miss
EPS Actual
-$0.30
EPS Est.
-$0.19
EPS Surpr.
-55.6%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $-0.30 | $-0.30 | $-0.30 | 1 |
| Q4 FY2025 | $-0.30 | $-0.30 | $-0.30 | 1 |
| Q3 FY2025 | $-0.45 | $-0.45 | $-0.45 | 1 |
| Q2 FY2025 | $-0.45 | $-0.45 | $-0.45 | 1 |
| Q1 FY2025 | $-0.30 | $-0.30 | $-0.30 | 1 |
| Q4 FY2024 | $-0.45 | $-0.45 | $-0.45 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2025 | Sep 10, 2025 | — | $5.33 | — | — |
| ▼ Q2 FY2025 | Jun 16, 2025 | -900.0% | $5.15 | $5.16 | +0.19% |
| — Q2 FY2025 | Apr 28, 2025 | — | $2.71 | $3.03 | +11.81% |
| ▼ Q4 FY2024 | Dec 16, 2024 | -1933.3% | $3.50 | $3.39 | -3.14% |
| ▼ Q3 FY2024 | Sep 11, 2024 | -25.0% | $6.75 | $7.23 | +7.11% |
| ▼ Q2 FY2024 | Jun 11, 2024 | -25.0% | $6.91 | $9.60 | +38.93% |
| ▼ Q2 FY2024 | Apr 29, 2024 | -50.0% | $4.82 | $4.65 | -3.53% |
| ▼ Q4 FY2023 | Dec 13, 2023 | -55.6% | $4.97 | $5.25 | +5.63% |
Q3 FY2025—
Report Date
Sep 10, 2025
EPS Beat/Miss
—
Price Before
$5.33
Price After
—
Q2 FY2025+0.19%
Report Date
Jun 16, 2025
EPS Beat/Miss
-900.0%
Price Before
$5.15
Price After
$5.16
Q2 FY2025+11.81%
Report Date
Apr 28, 2025
EPS Beat/Miss
—
Price Before
$2.71
Price After
$3.03
Q4 FY2024-3.14%
Report Date
Dec 16, 2024
EPS Beat/Miss
-1933.3%
Price Before
$3.50
Price After
$3.39
Q3 FY2024+7.11%
Report Date
Sep 11, 2024
EPS Beat/Miss
-25.0%
Price Before
$6.75
Price After
$7.23
Q2 FY2024+38.93%
Report Date
Jun 11, 2024
EPS Beat/Miss
-25.0%
Price Before
$6.91
Price After
$9.60
Q2 FY2024-3.53%
Report Date
Apr 29, 2024
EPS Beat/Miss
-50.0%
Price Before
$4.82
Price After
$4.65
Q4 FY2023+5.63%
Report Date
Dec 13, 2023
EPS Beat/Miss
-55.6%
Price Before
$4.97
Price After
$5.25
Avg Miss Reaction+7.53%
Beat Rate0 / 8 quarters
Largest Move+38.93% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: STRM ends December
Streamline Health Solutions, Inc. (STRM) most recently reported earnings on September 10, 2025 for Q3 FY2025, posting EPS of $-0.75 (in line with the analyst consensus of —). The next STRM earnings date is expected around September 1, 2026.
Each quarter, investors track STRM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. STRM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
STRM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
STRM earnings · 4 questionsStreamline Health Solutions, Inc.'s next earnings report is expected around September 1, 2026. STRM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; STRM historically reports after market close (AMC).
STRM earnings datewhen is STRM earningsSTRM next earnings datewhen does STRM report earningsSTRM earnings calendar
▸ Source: FMP · Streamline Health Solutions, Inc. SEC filings · US GAAP · Streamline Health Solutions, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026